Seltorexant

N/A

Report date: 2026/05/13 13:47:13
NME

Base Information

Drug NameSeltorexant
Drug Alias NameMIN-202JNJ-922JNJ-7922JNJ-42847922
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 antagonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsDepressive Disorder, MajorSubstance Abuse, OralRenal Insufficiency +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[34] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaIND
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesJanssen-Cilag International NvJanssen Pharmaceutical KkJanssen Cilag N.V./S.A.
Active IndicationsDepressive Disorder, MajorSubstance Abuse, OralRenal Insufficiency +[5] 
Inactive IndicationsSleep Initiation and Maintenance DisordersSleep Apnea, Obstructive

Other Information

ATC CodeN/A
Related LinksWikipedia